World's Best Scientists 2026 revealed!
Floris P. J. G. Lafeber

Floris P. J. G. Lafeber

Floris P. J. G. Lafeber publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Floris P. J. G. Lafeber sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

The last bar groups every scientist with 1,796 publications or more.

Floris P. J. G. Lafeber D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Floris P. J. G. Lafeber sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

The last bar groups every scientist with 217 D-Index or more.

Overview

Floris P. J. G. Lafeber is affiliated with Utrecht University in the Netherlands and has contributed extensively to the field of medical research, with a primary focus on rheumatology and related subfields. Their research work encompasses a broad range of topics mainly centered on osteoarthritis and rheumatoid arthritis, as well as surgical outcomes and hematology.

The scientist's main fields of study include:

  • Medicine

Within this domain, Lafeber's research contributions can be categorized into several subfields, including:

  • Rheumatology
  • Surgery
  • Hematology
  • Genetics
  • Pathology and Forensic Medicine

The primary research topics addressed by Lafeber include:

  • Osteoarthritis Treatment and Mechanisms
  • Rheumatoid Arthritis Research and Therapies
  • Total Knee Arthroplasty Outcomes
  • Knee injuries and reconstruction techniques
  • Hemophilia Treatment and Research
  • Lymphoma Diagnosis and Treatment
  • Systemic Lupus Erythematosus Research

Lafeber has published numerous scholarly articles, some of the recent papers being:

  • "Difficult-to-treat rheumatoid arthritis: contributing factors and burden of disease," 2020, Lara D. Veeken
  • "Dorsal Root Ganglia Macrophages Maintain Osteoarthritis Pain," 2021, Journal of Neuroscience
  • "Cohort profile: The Applied Public-Private Research enabling OsteoArthritis Clinical Headway (IMI-APPROACH) study: a 2-year, European, cohort study to describe, validate and predict phenotypes of osteoarthritis using clinical, imaging and biochemical markers," 2020, BMJ Open
  • "Knee joint distraction in regular care for treatment of knee osteoarthritis: A comparison with clinical trial data," 2020, PLoS ONE
  • "Healthcare utilization and economic burden of difficult-to-treat rheumatoid arthritis: a cost-of-illness study," 2021, Lara D. Veeken

The venues where Lafeber frequently publishes their work include:

  • Lara D. Veeken
  • Haemophilia
  • PLoS ONE
  • RMD Open
  • BMJ Open

Collaboration is also a significant aspect of Lafeber's academic output. Frequent co-authors include:

  • S.C. Mastbergen
  • Paco M J Welsing
  • Mylène P. Jansen
  • Janneke Tekstra
  • M. Kloppenburg

Best Publications

  • Osteoarthritis: an update with relevance for clinical practice

    Johannes W J Bijlsma;Francis Berenbaum;Floris P J G Lafeber

  • Effect of collagen turnover on the accumulation of advanced glycation end products.

    Nicole Verzijl;Jeroen DeGroot;Suzanne R. Thorpe;Ruud A. Bank

  • CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid.

    Jocea M. R. van Amelsfort;Kim M. G. Jacobs;Johannes W. J. Bijlsma;Floris P. J. G. Lafeber

  • Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: A possible mechanism through which age is a risk factor for osteoarthritis

    Nicole Verzijl;Jeroen DeGroot;Chaya Ben Zaken;Orit Braun-Benjamin

  • Ageing and zonal variation in post-translational modification of collagen in normal human articular cartilage. The age-related increase in non-enzymatic glycation affects biomechanical properties of cartilage.

    Ruud A. Bank;Michael T. Bayliss;Floris P. J. G. Lafeber;Alice Maroudas

  • Age-related accumulation of Maillard reaction products in human articular cartilage collagen.

    Nicole Verzijl;Jeroen Degroot;Esther Oldehinkel;Ruud A. Bank

  • Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial.

    Marije F. Bakker;Johannes W.G. Jacobs;Paco M.J. Welsing;Suzanne M.M. Verstappen

  • Modulation of monocyte/macrophage function by human CD4+CD25+ regulatory T cells

    Leonie S. Taams;Jocea M.R. van Amelsfort;Machteld M. Tiemessen;Kim M.G. Jacobs

  • Antigen-specific T cell suppression by human CD4+CD25+ regulatory T cells.

    Leonie S. Taams;Milica Vukmanovic-Stejic;Jay Smith;Padraic J. Dunne

  • Accumulation of advanced glycation end products as a molecular mechanism for aging as a risk factor in osteoarthritis

    Jeroen DeGroot;Nicole Verzijl;Marion J. G. Wenting-Van Wijk;Kim M. G. Jacobs

  • Proinflammatory mediator–induced reversal of CD4+,CD25+ regulatory T cell–mediated suppression in rheumatoid arthritis

    Jocea M. R. van Amelsfort;Joel A. G. van Roon;Madelon Noordegraaf;Kim M. G. Jacobs

  • Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early) : a multicentre, randomised, double-blind, double-dummy, strategy trial

    Johannes W J Bijlsma;Paco M J Welsing;Thasia G Woodworth;Leonie M Middelink

  • Comprehensive LC−MSE Lipidomic Analysis using a Shotgun Approach and Its Application to Biomarker Detection and Identification in Osteoarthritis Patients

    Jose M. Castro-Perez;Jurre Kamphorst;Jeroen DeGroot;Floris Lafeber

  • A simplified measurement of degraded collagen in tissues: Application in healthy, fibrillated and osteoarthritic cartilage

    R.A. Bank;M. Krikken;B. Beekman;R. Stoop

  • Short-Term Exposure of Cartilage to Blood Results in Chondrocyte Apoptosis

    Michel Hooiveld;Goris Roosendaal;Marion Wenting;Marijke van den Berg

  • Active involvement of alarmins S100A8 and S100A9 in the regulation of synovial activation and joint destruction during mouse and human osteoarthritis.

    Peter L. E. M. van Lent;Arjen B. Blom;Rik F. P. Schelbergen;Annet Slöetjes

  • Age-related decrease in proteoglycan synthesis of human articular chondrocytes: The role of nonenzymatic glycation

    Jeroen DeGroot;Nicole Verzijl;Ruud A. Bank;Floris P. J. G. Lafeber

  • Synergistic activity of interleukin-4 and interleukin-10 in suppression of inflammation and joint destruction in rheumatoid arthritis.

    Joel A. G. van Roon;Floris P. J. G. Lafeber;J. W. J. Bijlsma

  • Physiopathology of haemophilic arthropathy.

    F. P. J. G. Lafeber;P. Miossec;L. A. Valentino

  • Clinical benefit of joint distraction in the treatment of severe osteoarthritis of the ankle: Proof of concept in an open prospective study and in a randomized controlled study

    Anne C. A. Marijnissen;Peter M. Van Roermund;Jan Van Melkebeek;Willem Schenk

Frequent Co-Authors

Johannes W. J. Bijlsma
Johannes W. J. Bijlsma Utrecht University
Joel A G van Roon
Joel A G van Roon University Medical Center Utrecht
Jeroen DeGroot
Jeroen DeGroot Charles River Laboratories (Netherlands)
Harrie Weinans
Harrie Weinans Utrecht University
Ruud A. Bank
Ruud A. Bank University Medical Center Groningen
Johan M. TeKoppele
Johan M. TeKoppele Utrecht University
Max A. Viergever
Max A. Viergever Utrecht University
Timothy R D J Radstake
Timothy R D J Radstake Utrecht University
Thomas Hankemeier
Thomas Hankemeier Leiden University
Ali Mobasheri
Ali Mobasheri University of Oulu

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine opens doors to a variety of related online degrees that can enhance your skills and expand your professional options. Many students look beyond traditional MD programs to flexible online choices to suit different interests and schedules.

For those interested in mental health, online psych np programs offer a pathway to become a Psychiatric Mental Health Nurse Practitioner—an in-demand specialty combining patient care with mental health expertise.

If healthcare leadership or management appeals to you, there are healthcare administration degrees offered online at both undergraduate and graduate levels. These programs can prepare you for roles in hospital management, policy, or health services administration.

Career-minded professionals may also consider the most affordable online mha programs for a Master’s in Healthcare Administration. These degrees are designed for working adults who want to advance into leadership roles while balancing current commitments.

Lastly, nurses seeking the highest level of clinical expertise can choose from a range of cheap online dnp programs. A Doctor of Nursing Practice degree is ideal for those aiming for advanced practice, leadership, or academic positions.

Best Scientists Citing Floris P. J. G. Lafeber

Trending Scientists

Recently Published Articles